Sep
2
Las Vegas, NV – 02September, 2014– (TechSonian) – Immunomedics, Inc. (NASDAQ:IMMU) reported financial outcome for the fourth quarter and fiscal year finished June 30, 2014. The Company also highlighted recent key developments and planned activities for its clinical pipeline. Total revenues for the fourth quarter of fiscal year 2014, which finished on June 30, 2014, were $1.2 million as compared to total revenues of $1.4 million for the same quarter last fiscal year.
Immunomedics, Inc. (NASDAQ:IMMU)added 4.06%, trading on 588,764.00 shares, to end the trade at $3.33. The stock changed hands in a range of $3.15 – $3.33, bringing its market capitalization to about $310.07 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $3.04 on and was moved to the maximum level of $7.35.
Why Should Investors Buy IMMU After The Recent Gain? Just Go Here and Find Out
Texas Roadhouse Inc (NASDAQ:TXRH) Board of Directors authorized the payment of a cash dividend of $0.15 per share of common stock. This payment will be distributed on October 3, 2014, to shareholders of record at the close of business on September 17, 2014.
Texas Roadhouse Inc (NASDAQ:TXRH) flopped -0.15%, to complete the trading session at $26.59, with a total volume of 583,881.00 shares. The stock, on average, trades on a volume of 558,442.00 shares. It floated in a range of $26.35 – $26.66 during the last trading session, with a beta value of 0.80. Its market capitalization now moved to about $1.85 billion. In the past 52 weeks, the share price has not declined below $22.87 and above $29.07.
Has TXRH Found The Bottom And Ready To Gain Momentum? Find Out Here
GrupoFinanciero Galicia S.A. (ADR) (NASDAQ:GGAL) operates as a financial services holding company in Argentina. The company operates through Banking, Regional Credit Cards, CFA Personal Loans, and Insurance segments. It offers financial products and services, including collection and payment services, commercial credit cards, direct payroll deposits, capital market alternatives, foreign trade solutions, and corporate e-banking solutions; financial support and cash management services; foreign trade; corporate debt and securitization transactions; and e-collection and payment solutions to various agencies, municipalities, and universities.
GrupoFinanciero Galicia S.A. (ADR) (NASDAQ:GGAL) advanced of 0.71% and was in a range of $12.41 – $12.77 before closing at $12.68. The stock completed the day with a total volume of 579,361.00 shares, versus an average volume of 944,088.00 shares. The share price hit its 52-week low of $6.68 on Sep 3, 2013and $18.50 was the best price in the same period.
For How Long GGAL Gloss will Attract Investors? Find out via this report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported financial outcome for the second quarter finished June 30, 2014. Financial highlights for the second quarter include revenues of $18.4 million and a net loss of $16.3 million, or $0.13 per share. This compares to revenues of $14.5 million and a net loss of $22.9 million, or $0.20 per share, for the second quarter of 2013.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) added 0.42% yesterday, bringing its market capitalization around $1.19 billion. The share price, after opening at $9.49, made a high of $9.42 and hovered above $9.62 to end the day at $9.50. The total number of shares that changed hands during the session was 579,291.00 shares, as compared to average trading volume of 1.18 million shares.
Will HALO Continue To Move Higher? Find Out Here
Open all references in tabs: [1 – 5]
Comments
Leave a Reply
You must be logged in to post a comment.